- Home
- VTEX vs EBS Comparison
VTEX vs EBS Comparison
Compare VTEX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTEX | EBS |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.7M | 595.6M |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | VTEX | EBS |
|---|---|---|
| Price | $3.10 | $10.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $6.16 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.1M | 869.6K |
| Earning Date | 02-26-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.40 | N/A |
| EPS | 0.07 | ★ 1.35 |
| Revenue | $234,115,000.00 | ★ $788,900,000.00 |
| Revenue This Year | $8.35 | N/A |
| Revenue Next Year | $10.37 | $15.21 |
| P/E Ratio | $46.19 | ★ $8.17 |
| Revenue Growth | ★ 3.65 | N/A |
| 52 Week Low | $2.99 | $4.02 |
| 52 Week High | $6.89 | $14.06 |
Technical Indicators
Market Signals| Indicator | VTEX | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 40.69 |
| Support Level | $2.99 | $10.66 |
| Resistance Level | $3.40 | $11.45 |
| Average True Range (ATR) | 0.13 | 0.59 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 24.44 | 19.95 |
Price Performance
Historical ComparisonAbout VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.